Study on evolution of creatinine among patients under antiretroviral drugs. «Case Study of Muhima Hospital»

HIV/AIDS is a major problem of public health concern in the world especially in developing countries, including Rwanda. The reduction on impact of HIV infections is only done by prevention, monitoring and care of patients living with HIV/AIDS under antiretroviral therapy.There are currently 184 ARTs sites in Rwanda that perform laboratory tests to follow up and care to patients living with HIV/AIDS who are under antiretroviral therapy. It is very important to mention that this crucial activity of following up patients with HIV/AIDS who are under antiretroviral therapy have started in Rwanda since 2003 and there is no research published yet to indicate the side effects of ARVs on kidney functions among HIV/AIDS patients under ARVs treatment in Rwanda.  This is the reason why this study has been carried out to improve the care and better follow up of people living with HIV/AIDS infection.The general objective of this study was to determine whether creatinine is evolved in HIV/AIDS patients who are under ARVs treatments in Kigali rural areas. This study has been carried out at Laboratory of Muhima Hospital where biochemistry tests results from May 2012 up to June 2012 were used to see whether creatinine is evolved in kidney among HIV/AIDS patients under ARVs therapy.